Stephen John Wort

10PUBLICATIONS
64CO-AUTHORS
Cancer diagnosisImmunogenetics (incl. genetic immunology)Respiratory diseasesEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 11, 2026
Pathogenesis and Phenotypes of Pulmonary Vascular Disease in COPD: A Consensus Statement From the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - PH Group 3 Workstream.

|Dec 24, 2025
Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtype.

Ifan Jenkin, Konstantinos Dimopoulos, Steven D Nathan

|Aug 20, 2025
Significance of Pulmonary Vascular Dysfunction in Chronic Obstructive Pulmonary Disease.

Steven D Nathan, Lucilla Piccari, Steven H Abman

|Dec 11, 2024
Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH-CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative-group 3 pulmonary hypertension.

P Vitulo, L Piccari, S J Wort

|Jan 11, 2024
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension.

Oksana A Shlobin, Eric Shen, Stephen J Wort

|Jan 06, 2024
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension.

Anna Ulrich, Yukyee Wu, Harmen Draisma

Pageof 2

Frequent Collaborators

5 joint publications

Lucilla Piccari

5 joint publications

Steven D Nathan

4 joint publications

Sylvia M Nikkho

3 joint publications

Oksana A Shlobin